Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 360-360
Open Access | Times Cited: 21

Showing 21 citing articles:

Microbiota, Tryptophan and Aryl Hydrocarbon Receptors as the Target Triad in Parkinson’s Disease—A Narrative Review
Paulina Iwaniak, Maja Owe-Larsson, Ewa M. Urbańska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2915-2915
Open Access | Times Cited: 11
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 9
Role of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1462-1462
Open Access | Times Cited: 8
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 5
Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease
Ni Liu, Tianjiao Zhang, Wei Zhao, et al.
Ageing Research Reviews (2025), pp. 102658-102658
Closed Access
Therapeutic exploration potential of adenosine receptor antagonists through pharmacophore ligand-based modelling and pharmacokinetics studies against Parkinson disease
Abduljelil Ajala, Otaru Habiba Asipita, Abatyough Terungwa Michael, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
IL-2/anti-IL-2 complexes attenuates neuroinflammation and neurodegeneration in mice of experimental Parkinson's disease.
Lanxin Li, Weiwei Gao, Ning Ren, et al.
Brain Research Bulletin (2025), pp. 111273-111273
Open Access
Current amyloid inhibitors: therapeutic applications and nanomaterial-based innovations
Paula López-García, María M. Tejero-Ojeda, Marisela Morales, et al.
Progress in Neurobiology (2025), pp. 102734-102734
Closed Access
Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
Ran Zhao, Nan Jia, Shuyang Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 141814-141814
Closed Access
Clinical Predictors of Freezing of Gait in Patients with Parkinson's Disease: A Systematic Review
Sohaila Alshimemeri, A M Alhayssoni, R. HAZAZI
Clinical Neurology and Neurosurgery (2025) Vol. 252, pp. 108848-108848
Closed Access
Exploring Alzheimer's Disease Treatment: Established Therapies and Novel Strategies for Future Care
Urvashi Soni, Kuldeep Singh, Divya Jain, et al.
European Journal of Pharmacology (2025), pp. 177520-177520
Closed Access
Redox modulatory role of DJ-1 in Parkinson’s disease
Qamar A. Alshammari
Biogerontology (2025) Vol. 26, Iss. 2
Closed Access
The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
Huanhuan Xiang
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates
Ahmed A. Elbatrawy, Taiwo A. Ademoye, Heba Alnakhala, et al.
ACS Omega (2025) Vol. 10, Iss. 7, pp. 6721-6734
Open Access
Small Molecules, α-Synuclein Pathology, and the Search for Effective Treatments in Parkinson’s Disease
GianPietro Sechi, Maria Margherita Sechi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11198-11198
Open Access | Times Cited: 3
Evidence for prodromal changes in neuronal excitability and neuroinflammation in the hippocampus in young alpha-synuclein (A30P) transgenic mice
Ibtisam Al-Musawi, Bethany H. Dennis, Gavin J. Clowry, et al.
Frontiers in Dementia (2024) Vol. 3
Open Access | Times Cited: 2
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 1
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation
Yaoyun Kuang, Hengxu Mao, Xiaoyun Huang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
ADrosophilamodel for mechanistic investigation of tau protein spread
Kondalarao Bankapalli, Ruth E. Thomas, Evelyn S. Vincow, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gray matter volume alterations in de novo Parkinson's disease: A mediational role in the interplay between sleep quality and anxiety
Guixiang He, Xiaofang Huang, Haihua Sun, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access
A Drosophila model for mechanistic investigation of tau protein spread
Kondalarao Bankapalli, Ruth E. Thomas, Evelyn S. Vincow, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 9
Open Access
An Insight into Fisetin, The Miraculous Multifaceted Flavonol: Paving the Road for Enhanced Delivery Through Promising Pharmaceutical Nano-Formulations.
Asmaa H. Elwan, Soha M. El-Masry, Doaa A. Habib, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106292-106292
Closed Access
Page 1

Scroll to top